Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-03

Clinical Trial Update: Effect of Oral Helicobacter Pylori Infection on the Efficacy of Gastroluminal Helicobacter Pylori Eradication Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether oral Helicobacter pylori infection influences the efficacy of gastroluminal Helicobacter pylori eradication the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gastroluminal Helicobacter pylori Eradication Therapy

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Helicobacter Pylori | Phase 4 | Status: COMPLETED